885273-89-2 Usage
Uses
Used in Pharmaceutical Industry:
MORPHOLINE-3-ACETIC ACID METHYL ESTER is used as an active pharmaceutical ingredient for its potential in treating various diseases. Its ability to inhibit microbial growth makes it a candidate for the development of new drugs.
Used in Pesticide Industry:
In the pesticide industry, MORPHOLINE-3-ACETIC ACID METHYL ESTER is used as an antifungal and antibacterial agent. Its properties allow it to control the growth of harmful microorganisms that can damage crops and other products.
Used as a Herbicide:
MORPHOLINE-3-ACETIC ACID METHYL ESTER is utilized as a herbicide to control the growth of unwanted plants. Its effectiveness in inhibiting microbial growth translates to its ability to manage plant populations in agricultural settings.
Used as a Plant Growth Regulator:
This chemical compound is also employed as a plant growth regulator, helping to manage and control the growth patterns of plants, which can be beneficial in optimizing crop yields and quality.
Overall, MORPHOLINE-3-ACETIC ACID METHYL ESTER is a multifaceted chemical with applications spanning across different fields, and it continues to be a subject of research for its potential uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 885273-89-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 3 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 885273-89:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*3)+(2*8)+(1*9)=222
222 % 10 = 2
So 885273-89-2 is a valid CAS Registry Number.
InChI:InChI=1/C7H13NO3/c1-10-7(9)4-6-5-11-3-2-8-6/h6,8H,2-5H2,1H3
885273-89-2Relevant academic research and scientific papers
TRICYCLIC COMPOUNDS AND COMPOSITIONS AS KINASE INHIBITORS
-
Paragraph 00211; 00214, (2017/07/06)
The present invention provides compounds of Formula (A): (I) as described herein, and salts thereof, and therapeutic uses of these compounds for treatment of disorders associated with Raf kinase activity. The invention further provides pharmaceutical compositions comprising these compounds, and compositions comprising these compounds and a therapeutic co-agent, and methods of using the compositions and combinations to treat conditions including cancers.
